Overview

TNT Versus Conventional CRT to Increase the Sphincter Preservation Rate for Distal LARC

Status:
Recruiting
Trial end date:
2023-12-30
Target enrollment:
Participant gender:
Summary
TNT versus. conventional CRT for distal locally advanced rectal cancer (TESS)
Phase:
Phase 2
Details
Lead Sponsor:
Sun Yat-sen University
Treatments:
Capecitabine
Oxaliplatin